Total Liabilities Equity - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

NuVasive Inc
Total Liabilities & Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Total Liabilities & Equity
$2.1B
CAGR 3-Years
-8%
CAGR 5-Years
5%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Total Liabilities & Equity
$55.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
16%
Boston Scientific Corp
NYSE:BSX
Total Liabilities & Equity
$37.1B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Total Liabilities & Equity
$39.1B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Liabilities & Equity
$73B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Liabilities & Equity
$16.6B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is NuVasive Inc's Total Liabilities & Equity?
Total Liabilities & Equity
2.1B USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Total Liabilities & Equity amounts to 2.1B USD.

What is NuVasive Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
7%

Over the last year, the Total Liabilities & Equity growth was -4%. The average annual Total Liabilities & Equity growth rates for NuVasive Inc have been -8% over the past three years , 5% over the past five years , and 7% over the past ten years .

Back to Top